NASONEX ninasprei, suspensioon এস্তোনিয়া - এস্তোনীয় - Ravimiamet

nasonex ninasprei, suspensioon

organon n.v. - mometasoon - ninasprei, suspensioon - 50mcg 1annus 140annus 2tk; 50mcg 1annus 140annus 1tk

SINEMET 25/100 tablett এস্তোনিয়া - এস্তোনীয় - Ravimiamet

sinemet 25/100 tablett

organon n.v. - levodopa+karbidopa - tablett - 100mg+25mg 30tk; 100mg+25mg 56tk; 100mg+25mg 60tk; 100mg+25mg 28tk

ELOCON salv এস্তোনিয়া - এস্তোনীয় - Ravimiamet

elocon salv

organon n.v. - mometasoon - salv - 1mg 1g 20g 1tk; 1mg 1g 50g 1tk

SINEMET CR 50/200 MG toimeainet prolongeeritult vabastav tablett এস্তোনিয়া - এস্তোনীয় - Ravimiamet

sinemet cr 50/200 mg toimeainet prolongeeritult vabastav tablett

organon n.v. - levodopa+karbidopa - toimeainet prolongeeritult vabastav tablett - 200mg+50mg 100tk

REMERON SOLTAB suus dispergeeruv tablett এস্তোনিয়া - এস্তোনীয় - Ravimiamet

remeron soltab suus dispergeeruv tablett

organon n.v. - mirtasapiin - suus dispergeeruv tablett - 30mg 6tk; 30mg 30tk; 30mg 48tk; 30mg 96tk; 30mg 18tk

Adrovance ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

adrovance

n.v. organon - colecalciferol, alendronic acid (as sodium trihydrate) - osteoporoos, postmenopausis - narkootikumid luuhaiguste raviks - menopausijärgse osteoporoosi ravi d-vitamiini puudulikkusega patsientidel. adrovance vähendab lülisamba ja puusaluu murrud.

Aerinaze ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

aerinaze

n.v. organon - desloratadine, pseudophedrine sulfate - riniit, allergiline, hooajaline - nina preparaadid - hooajalise allergilise riniidi sümptomaatiline ravi, kui sellega kaasneb ninakinnisus.

Elonva ইউরোপীয় ইউনিয়ন - এস্তোনীয় - EMA (European Medicines Agency)

elonva

n.v. organon - korifollitropiin alfa - reproductive techniques, assisted; ovulation induction; investigative techniques - suguhormoonid ja genitaalsüsteemi, - controlled ovarian stimulation (cos) in combination with a gnrh antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (art) program. elonva is indicated for the treatment of adolescent males (14 to less than 18 years and older) with hypogonadotropic hypogonadism, in combination with human chorionic gonadotropin (hcg).